Single Blinded First CMC Osteoarthritis Treatment

Description

Single blinded PRP vs. Corticosteroid vs. Placebo (normal saline) intra-articular injection for basal joint arthritis.

Conditions

Osteoarthritis Thumb

Study Overview

Study Details

Study overview

Single blinded PRP vs. Corticosteroid vs. Placebo (normal saline) intra-articular injection for basal joint arthritis.

Randomized Single Blinded First CMC Osteoarthritis Treatment: Therapy and Bracing Alone vs. Intra-Articular Corticosteroid Injection vs Intra-Articular Leukocyte Depleted Platelet Rich Plasma

Single Blinded First CMC Osteoarthritis Treatment

Condition
Osteoarthritis Thumb
Intervention / Treatment

-

Contacts and Locations

Centerville

Orthopedic Associates of Southwest Ohio, Centerville, Ohio, United States, 45459

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Stage 1-3 osteoarthritis of the basal joint
  • * Patients with Stage 4 1st carpometacarpal joint arthritis as described by Eaton
  • * Patients who have received a corticosteroid injection in the last year to the 1st CMC joint on the proposed study side
  • * Patients who have scaphotriquetral, radioscaphoid, or scaphotrapezial osteoarthritis
  • * Patients who have concurrent DeQuervain's tenosynovitis or intersection syndrome or have been treated for either of these in the last 3 months
  • * Patients undergoing evaluation of cervical radiculopathy
  • * Patients with fibromyalgia or inflammatory rheumatic disease
  • * Patients with Pressier disease, Kienbock's, or avascular necrosis of the scaphoid
  • * Patients with any history of primary or secondary bone tumor
  • * Patients that are pregnant or terminally ill

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Kettering Health Network,

Study Record Dates

2025-03-31